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http://dx.doi.org/10.1016/j.jmii.2015
1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: Acanthamoeba keratitis (AK), a painful infectious corneal
disease, is caused by the free-living pathogenic species Acanthamoeba. The symptoms include
corneal infiltrate, epithelial, and stromal destruction, and loss of vision. Current treatment
generally involves an hourly application of polyhexamethylene biguanide (PHMB) over a period
of several days; however, even this is not entirely effective against all strains/isolates. The
aims of this study were to confirm the existence of pathogenic strains in Taiwan which are high-
ly resistant to drugs and to characterize the behavior of these strains.
Methods: An in vitro Acanthamoeba species culture platform was established to observe the
effectiveness of treatment and chart the morphological changes that occur under the effects
of drugs using a light microscope and time-lapse recording. Changes in gene expression were
examined using reverse transcription polymerase chain reaction (RT-PCR) and real-time PCR.
Results: Over 90% of the standard strain cells (ATCC 30010) were lysed after being treated with
PHMB for 1 hour; however, clinical isolates of Acanthamoeba castellanii that differed in their
susceptibility to the treatment drug were only partly lysed. Following treatment with PHMB,
National Cheng Kung University Hospital isolation B (NCKH_B) transformed into a pseudocyst
under the effects of drug stress; however, National Cheng Kung University Hospital isolation
D (NCKH_D), an isolate with higher tolerance for PHMB, did not transform.of Parasitology, National Cheng Kung University, Number 1, University Road, Tainan City 701, Taiwan.
ku.edu.tw (W.-C. Lin).
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j.jmii.2015.10.011Conclusion: Our results confirm the existence of clinical isolates of A. castellanii with high
resistance to PHMB in Taiwan and present the alternative drug tolerance of A. castellanii in
addition to the transformation of pseudocyst/cyst.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Acanthamoeba keratitis (AK) is a serious and very painful,
corneal infection caused by pathogenic protozoans of the
genus Acanthamoeba.1,2 Acanthamoeba species are ubiq-
uitous, free-living protozoa which exist as motile tropho-
zoites and dormant cysts in the wide range of amoebae
found in swimming pools, hot tubs, lakes, soil, dust, and
drinking fountains.3 Clinical cases of AK are largely
restricted to contact lens wearers who have experienced
trauma to their corneal epithelium.4e7 In the trophozoite
stage, Acanthamoeba feed on organic particles and mi-
crobes, and divide mitotically under optimal conditions.
Under exposure to a harsh environment or during periods of
stress, the cells can transform into double-walled cysts.
The inner wall is comprised of cellulose, and the outer wall
consists of proteins and polysaccharides. The largest in-
creases in drug resistance occur during encystation.
The past two decades have seen a remarkable increase
in the number of cases of severe ocular inflammation and
visual loss caused by Acanthamoeba infections. The greater
prevalence of Acanthamoeba infections has been linked to
an increase in contact lens use.3,8e10 The first two cases of
AK in Taiwan were confirmed by corneal biopsy in 1988.11
According to medical records at National Taiwan Univer-
sity Hospital, Taipei, Taiwan for the period from January
1992 to December 2001, 4.4% of microbial keratitis cases
were caused by Acanthamoeba.12 Difficulties in obtaining
an early diagnosis and poor response to most antibiotics
have led to the use of therapeutic penetrating keratoplasty
as a means of eradicating the pathogens in cases of un-
controlled disease. A failure to diagnose this infection early
and initiate aggressive treatment can lead to extensive
ocular damage, including ring-like corneal infiltration,
epithelial destruction, and severe ocular pain. In such
cases, enucleation may be required.9 Confirmation of AK by
laboratory diagnosis is the first step in treating this vision-
threatening disease, and culturing on non-nutrient agar
with an Escherichia coli overlay is considered the most
effective method of diagnosis. Indeed, rapid diagnosis of
pathogens and prompt initiation of appropriate antibiotic
therapy are crucial in reducing the morbidity associated
with AK.13
Currently, the treatment regimen in Taiwan involves
hourly drug applications for prolonged periods.2,14,15
Nonetheless, clinical outcomes tend to be poor, particu-
larly in cases involving drug resistant/tolerant strains.
Among drugs used to treat AK, polyhexamethylene bigua-
nide (PHMB) is a membrane-active agent with broad-
spectrum antimicrobial efficacy that is commonly used as
an antiseptic to deal with keratitis13e16 in areas such asang F-C, et al., Characterizing cl
aiwan, Journal of Microbiology,swimming pools and cooling systems.17 PHMB is a mixture of
polymeric biguanides with an approximate molecular
weight range of 400e8000. The structure of PHMB is as
follows: [-(CH2)6.NH.C(ZNH).NH.C(ZNH).NH-]n, where
n Z 2e40. In previous studies on prokaryotic cells, PHMB
was shown to interact with cytoplasmic membranes to
cause the lethal action, nonspecific alterations in mem-
brane integrity, loss of Lipopolysaccharides (LPS), and loss
of function in membrane proteins.10,18,19 PHMB has also
been shown to interfere with prokaryotic cell functions by
binding to nucleotides,8 and the drug is further believed to
cause the production of large quantities of phosphorus,
which accumulates in the nuclei of Acanthamoeba cas-
tellanii cells as a result of reduced permeability and pro-
tein coagulation or the aggregation of phospholipids.20
Trophozoites have been reported to adsorb more bigua-
nides than do cysts. Complex PHMB-nucleotide formations
have been observed near the cell wall and nuclei following
drug uptake by Acanthamoeba. However, the mechanism
underlying the resistance to PHMB by Acanthamoeba cells
has yet to be elucidated.
It is important to understand the actions of drugs and
mechanisms underlying tolerance in Acanthamoeba in order
to avoid medication failure and improve the effectiveness
of therapy for patients suffering from AK. Our results show
that A. castellanii clinical isolates National Cheng Kung
University Hospital isolation B (NCKH_B) and National Cheng
Kung University Hospital isolation D (NCKH_D) have higher
tolerance toward PHMB than does the standard strain, ATCC
30010. These two isolates differ in their response to PHMB
stress: NCKH_B transforms into a pseudocyst to escape the
drug, but NCKH_D does not. This study sought to charac-
terize the mechanisms underlying the resistance of Acan-
thamoeba to PHMB in order to facilitate the development
of a more effective treatment regimen for AK.Methods
Culture of Acanthamoeba protozoa
Acanthamoeba species were axenically cultured in a pro-
teose peptone-yeast extract-glucose medium, pH 6.5, at
28C in cell culture flasks. Trophozoites were harvested at
the logarithmic growth phase after being cultivated for
3e5 days. The clinical isolates were isolated from the
corneal ulcer of patients who were diagnosed as having AK
in the National Cheng Kung University Hospital (NCKUH),
Tainan, Taiwan.21 The use of material from patients was
reviewed and approved by the Committee of the Institu-
tional Review Board of NCKUH.inical isolates of Acanthamoeba castellanii with high resistance to
Immunology and Infection (2015), http://dx.doi.org/10.1016/
Table 1 Characterization of Acanthamoeba clinical isolates.
Strain Genotype
(18S ribosomal DNA)
Risk factor Early/late keratitis
at presentation
NCKH_B Acanthamoeba castellanii T4 SCL Early Medical success
NCKH_D A. castellanii T4 SCL Late Surgery
SCL Z soft contact lens.
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PHMB was prepared in different concentrations in Page’s
amoeba saline. To further clarify the appropriate amount of
cells, drug concentration, and duration of drug experiment,
the counted cells were added in the drug solution and
placed on a 100 rpm rotary shaker.
Growth curve and survival rate
Detached cells were centrifuged (1000 g) and the pellet was
suspended in a 0.5% trypan blue solution in sterile Phos-
phate-buffered saline (PBS) buffer for 1 minute. Cells were
then counted in a Neubauer hemocytometer chamber, and
the stained cells were considered dead. Cell counting was
performed under a light microscope to determine the
numbers of live and dead cells, which were differentiated
with the trypan blue dye exclusion viability method. The
number of stained cells was subtracted from the total,
indicating the death ratio in each interaction condition and
time.
Light and fluorescence microscopy
Microscope of Cell (Olympus America, Inc., Melville, NY,
USA) was used for the light and fluorescence microscopy
observations in this study. Cell is a fully motorized epi-
fluorescence microscope equipped with a fast excitation
and emission filter wheel allowing for fast multicolor three-
dimensional imaging. Image analysis software was used
with the microscope.
Total RNA isolation
The Total RNA Extraction Miniprep System (GR1001, Vio-
gene) was used. The cells were centrifuged at 13,500 rpm
for 5 minutes, 350 mL RX buffer was then added, the lysate
was centrifuged for 5 minutes to spin down insoluble ma-
terials, and only the supernatant was used in the following
steps. The final volume of the supernatant was determined.
An equal volume of 70% ethanol was added to the clear
lysate and mixed by vortexing. A Total RNA Mini Column was
placed onto a collection tube. Then 700 mL of the ethanol-
added sample (including any precipitate) was added into
the column and centrifuged for 30e60 seconds. The flow-
through was discared. Then the column was washed once
with 0.5 mL WF buffer by centrifuging for 30e60 seconds.
The flow-through was discared. The column was washed
once with 0.7 mL WS buffer by centrifuging for
30e60 seconds. The flow-through was discarded. The col-
umn was then centrifuged for another 3 minutes to removePlease cite this article in press as: Huang F-C, et al., Characterizing cl
polyhexamethylene biguanide in Taiwan, Journal of Microbiology,
j.jmii.2015.10.011ethanol residue. Next, the column was placed onto a 1.5 mL
RNase-free elution tube and 30e50 mL RNase-free ddH2O
was added onto the membrane. The column was allowed to
stand for 1 minute, then centrifuged for 1e2 minutes to
elute total RNA. The RNA was stored at 70C. The entire
concentration and A260/A280 ratio of mRNA was measured
with ND-1000 (NanoDrop).
cDNA synthesis
High capacity cDNA reverse transcription (RT) kits (4368813,
Applied Biosystems) were used in this study. To prepare the
2  RT master mix (per 20 mL reaction), the kit components
were allowed to thaw on ice. The volume of components
needed to prepare the required number of reactions were
calculated: 10  RT buffer 2.0 mL, 25  deoxynucleotide
(dNTP) mix (100mM) 0.8 mL, 10  RT random primers 2.0 mL,
MultiScribe Reverse Transcriptase 1.0 mL, nuclease-free H2O
4.2 mL, total per reaction 10.0 mL. RT conditions were set at
the following times and temperatures: 25C 10 minutes,
37C 120 minutes, 85C 5 minutes, 4C N. The reaction
volume was set to 20 mL.
RT polymerase chain reaction
One step RT polymerase chain reaction (RT-PCR) was per-
formed with SuperScript One-Step RT-PCR with Platinum
Taq kit (12574-018, Invitrogen) to investigate the gene
expression of Acanthamoeba spp. of the cyst-specific pro-
tein (CSP21), cellulose synthase II (CSII).22 All of the cDNA
was synthesized from 1 mg of total RNA of Acanthamoeba.
RT-PCR products were separated on Ethidium bromide
(EtBR)-stained gel after electrophoresis in 1.0e1.2%
agarose. The primers sequences for CSII were ACGA-
GATGGAGAGCATCCAG (forward) and CAG-
CACCTCGGTGTTGTAGA (reverse), and for CSP21
ACTCCTTCAGGTCGTCCA (forward) and
TTCTCCTCGAGGCCCATGTC (reverse).
Results
A. castellanii was collected from the corneal ulcers of pa-
tients diagnosed with AK at NCKUH. The collected A. cas-
tellanii presented a variety of pathogenicities and various
degrees of susceptibility to PHMB. After the culture, 18s
ribosomal DNA sequences (Rns) were used for sequencing
and genotyping. Identification of Acanthamoeba Rns geno-
types was based on sequences of 113 bp within the genus-
specific amplicon ASA.S1. From the results, we confirmed
two clinical isolates: NCKH_B, which is susceptible to PHMB
treatment, and NCKH_D, which is not susceptible to PHMBinical isolates of Acanthamoeba castellanii with high resistance to
Immunology and Infection (2015), http://dx.doi.org/10.1016/
Figure 1. Human cornea tissue infected by National Cheng Kung University Hospital isolation B (NCKH_B): (A) 48 hours post-
infection; (B) 96 hours postinfection and NCKH_D (C) 48 hours postinfection; (D) 96 hours postinfection. The arrows indicate the
position of the Acanthamoeba cell.
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lates is listed in Table 1. Both of these isolates belong to Rns
genotype T4 strains, the predominant Rns genotype found
in AK infections (data not shown). To evaluate the ability ofPlease cite this article in press as: Huang F-C, et al., Characterizing cl
polyhexamethylene biguanide in Taiwan, Journal of Microbiology,
j.jmii.2015.10.011these isolates to spread infection, we cocultured the A.
castellanii with human cornea tissue using the ATCC 30010
strain (standard nonpathogenic strain) as a control. Staining
with hematoxylin and eosin was performed on infectedinical isolates of Acanthamoeba castellanii with high resistance to
Immunology and Infection (2015), http://dx.doi.org/10.1016/
Figure 2. The light observation for effect imaging of addition of 0.01% polyhexamethylene biguanide (PHMB) to the live
Acanthamoeba strains by time-lapse recording: (A) the captured images; (B) the statistical results of the survival rate (log-rank test
on KaplaneMeier estimates of survival).
Figure 3. Effects of Acanthamoeba strains during the
progress of polyhexamethylene biguanide (PHMB) treatment. *
Means are significantly different at p < 0.05 by Student t test.
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cells were present in all tissue sections infected with
NCKH_B for 48 hours (Figure 1A) or 96 hours (Figure 1B) and
in tissue sections infected with NCKH_D for 48 hoursPlease cite this article in press as: Huang F-C, et al., Characterizing cl
polyhexamethylene biguanide in Taiwan, Journal of Microbiology,
j.jmii.2015.10.011(Figure 1C) or 96 hours (Figure 1D). In the tissues cocultured
with the ATCC 30010 control, no A. castellanii cells were
observed.
To elucidate the effectiveness of PHMB treatment, we
established an in vitro drug test platform for species of
Acanthamoeba. This treatment involved the hourly appli-
cation of 0.02% PHMB in the form of eye drops (200 mg/mL)
over a prolonged period. This experiment was conducted in
accordance with a previous report and counted the reliable
PHMB concentration in the eyes. Because there are tears in
eyes, the initial PHMB concentration in the eye must
be < 200 mg/mL and decreased rapidly (the turnover rate is
8.2% per minute).23 Seven minutes after applying the eye
drops, the drug concentration is expected to drop below
100 mg/mL. To mimic clinical treatment situations, the A.
castellanii isolates were treated with a similar concentra-
tion of PHMB as that encountered after administration and
serial dilution in an actual eye. Our results indicated that at
100 mg/mL, the effectiveness of PHMB in the treatment of
A. castellanii was close to that observed when PHMB is
administered to patients using an eye-dropper. To identify
the susceptibilities of ATCC30010, NCKH_B, and NCKH_D to
PHMB, we treated parasites with 100 mg/mL PHMB and
monitored the results using time-lapse recording obtained
with a differential interference contrast microscope.inical isolates of Acanthamoeba castellanii with high resistance to
Immunology and Infection (2015), http://dx.doi.org/10.1016/
Figure 4. The correlative ratio of pseudocysts-trophozoites
to (A) NCKH_B and (B) NCKH_D during the progress of
polyhexamethylene biguanide (PHMB) treatment.
Figure 5. Reverse transcription polymerase chain reaction
(RT-PCR) analysis of the gene expression level of
polyhexamethylene biguanide (PHMB)-treated clinical isolates
NCKH_B, NCKH_D, and ATCC 30010. Csp21, the marker of cyst;
CS II (cellulose synthase II), the marker of pseudocyst; the 18S
rDNA expression, used as a control.
Figure 6. Growth rates (percentage increase per hour) of
ATCC 30010 and NCKH_D at different temperatures.
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32.5 minutes. To quantify the number of live cells in the
images and calculate the survival rate of cells (as per
description in Methods) during the experiments could
reveal the effect of the drug on the Acanthamoeba strains/
isolates. From the survival analysis results by the
KaplaneMeier method and log-rank test,24 the tolerance of
both clinical isolates to PHMB exceeded that of ATCC30010,
with NCKH_D presenting the greatest tolerance (Figure 2).
In order to characterize the mode(s) of live A. castellanii
cells in resisting the stress associated with PHMB treat-
ment, we extended the treatment period and monitored
the survival rate every hour. After being treated with PHMB
at a concentration of 100 mg/mL, > 90% of the cells
belonging to the standard strain ATCC 30010 had been
lysed. By contrast, only 70% of the NCKH_B and 60% of the
NCKH_D had been lysed within the first hour. After 2 hours,
about 80% of NCKH_B isolates and 70% of NCKH_D isolates
were lysed (Figure 3). Between 3 hours and 6 hours, survival
rates did not change significantly from those observed afterPlease cite this article in press as: Huang F-C, et al., Characterizing cl
polyhexamethylene biguanide in Taiwan, Journal of Microbiology,
j.jmii.2015.10.011the 2nd hour (data not shown). Throughout the course of
PHMB treatment, a population of the NCKH_B and the
NCKH_D isolates were found to survive, having transformed
into pseudocysts. This behavior was not observed in the
ATCC strain. Throughout the PHMB treatment period, the
correlative ratio of pseudocysts-trophozoites to live
NCKH_B cells increased; however, this was not observed in
the NCKH_D cells (Figure 4). To confirm the different re-
sponses of the isolates, we checked the correlative gene
expression level of the A. castellanii encystation and
pseudocyst transformation.22 Our results show that gene
expression for Csp21, the marker associated with cyst
transformation, was not detected (Figure 5). During the
progress of PHMB treatment, the gene expression levels of
CSII, the key enzyme in pseudocyst transformation, were
higher in the NCKH_B than in ATCC 30010. Interestingly, the
expression of CSII in NCKH_D during the progress of PHMBinical isolates of Acanthamoeba castellanii with high resistance to
Immunology and Infection (2015), http://dx.doi.org/10.1016/
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pseudocysts-trophozoites to live NCKH_D cells did not
appear to change significantly.
In a previous study, Nielsen et al25 reported that the
optimal growth temperature for the four strains of A. cas-
tellanii (32C) is close to the surface temperature of the
human cornea. We tested the growth rates of NCKH_D and
ATCC 30010 at different temperatures and found that the
optimal growth temperature of NCKH_D is around 38C
(Figure 6). It is not only higher than ATCC 30010, but also
than the strains which Nielsen et al25 reported. In addition,
Jensen et al26 reported that doubling time for A. castellanii
is as low as 6 hours, with a maximal growth rate of 11.5%
per hour. From our results, the maximal growth rate of the
NCKU_D is 16.76% per hour. The clinical isolate, NCKH_D, is
a rapid-growth pathogenic strain with high PHMB
resistance.Discussion
AK is a major cause of severe ocular inflammation,
epithelial and stromal destruction, and loss of vision, which
can eventually necessitate eyeball removal. Unfortunately,
none of the medical or surgical treatments for AK have
proven consistently reliable. At present, treatment involves
hourly applications of PHMB over a prolonged period;
however, even this aggressive approach is unable to ensure
anything other than a poor prognosis. Obtaining reliable
data related to the efficacy of treatment methods and the
isolation of clinical strains with various degrees of drug
susceptibility, are the first crucial steps in developing a
more effective treatment regimen for AK. In this study,
clinical isolates of A. castellanii were collected, their sus-
ceptibility to PHMB identified, and their behavior when
challenged with this drug was characterized.
Previous researchers have reported that PHMB acts on
intracystic amoebae by shrinking them and by separating
the plasma membrane from the endocystic wall.27 The
images obtained in this study show that PHMB triggers the
rupturing of Acanthamoebal trophozoite cells into frag-
ments. Extending PHMB treatment resulted in an increase
in the population of surviving NCKH_B cells, which had
transformed into pseudocysts. Clearly, the PHMB resistance
of NCKH_B far exceeds that of the ATCC30010 strain.
The highest PHMB tolerant isolate, NCKH_D, did not
depend on transforming to escape the drug mainly, but the
RNA expression levels of CSII were constant in high levels,
even without drug treatment. From our observation, most
of the live NCKH_D cells were non-motile to maintain shape
during the PHMB treating. When we removed the drug and
replaced the fresh medium, a part of the NCKH_D cells soon
regained activity (data not shown). Clarification of the
PHMB tolerance/resistance mechanisms of highly tolerant
isolates like NCKH_D is needed.
Clinical isolates of A. castellanii obtained in Taiwan,
which show a pronounced tolerance for PHMB, were
characterized in this study. Furthermore, we present the
alternative drug tolerance of A. castellanii in addition to
the transformation of pseudocysts/cysts. This study has
begun to elucidate the behavior of A. castellanii in
resisting PHMB; our findings are a first step towardsPlease cite this article in press as: Huang F-C, et al., Characterizing cl
polyhexamethylene biguanide in Taiwan, Journal of Microbiology,
j.jmii.2015.10.011improving clinical therapies for patients infected with
drug-resistant AK.Conflicts of interest
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